IRIS

Sfoglia per Rivista  CANCER TREATMENT REVIEWS

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 31
Titolo Data di pubblicazione Autore(i) File
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now? 1-gen-2019 Tsaur, I; Heidegger, I; Kretschmer, A; Borgmann, H; Gandaglia, G; Briganti, A; de Visschere, P; Mathieu, R; Valerio, M; van den Bergh, R; Ost, P; Mirvald, C; Tilki, D; Ploussard, G; Surcel, C
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 1-gen-2014 Giampieri, R.; Scartozzi, M.; Del Prete, M.; Fulli, A.; Faloppi, L.; Bianconi, M.; Maccaroni, E.; Cascinu, S.
Assessment of tumor response in malignant pleural mesothelioma 1-gen-2007 Ceresoli, Gl; Chiti, A; Zucali, Pa; Cappuzzo, F; De Vincenzo, F; Cavina, R; Rodari, M; Poretti, D; Lutman, Fr; Santoro, A
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review 1-gen-2021 Meattini, I.; Becherini, C.; Bernini, M.; Bonzano, E.; Criscitiello, C.; De Rose, F.; De Santis, M. C.; Fontana, A.; Franco, P.; Gentilini, O. D.; Livi, L.; Meduri, B.; Parisi, S.; Pasinetti, N.; Prisco, A.; Rocco, N.
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 1-gen-2022 Fallara, Giuseppe; Robesti, Daniele; Nocera, Luigi; Raggi, Daniele; Marandino, Laura; Belladelli, Federico; Montorsi, Francesco; Malavaud, Bernard; Ploussard, Guillaume; Necchi, Andrea; Martini, Alberto
Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives 1-gen-2019 Macchini, M.; Chiaravalli, M.; Zanon, S.; Peretti, U.; Mazza, E.; Gianni, L.; Reni, M.
Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives 1-gen-2019 Pagani, F; Colecchia, M; Sepe, P; Apollonio, G; Claps, M; Verzoni, E; de Braud, F; Procopio, G
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 1-gen-2021 Bartoletti, M; Musacchio, L; Giannone, G; Tuninetti, V; Bergamini, A; Scambia, G; Lorusso, D; Valabrega, G; Mangili, G; Puglisi, F; Pignata, S
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 1-gen-2022 Macchini, M.; Centonze, F.; Peretti, U.; Orsi, G.; Militello, A. M.; Valente, M. M.; Cascinu, S.; Reni, M.
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer 1-gen-2021 Partelli, S.; Sclafani, F.; Barbu, S. T.; Beishon, M.; Bonomo, P.; Braz, G.; de Braud, F.; Brunner, T.; Cavestro, G. M.; Crul, M.; Trill, M. D.; Ferolla, P.; Herrmann, K.; Karamitopoulou, E.; Neuzillet, C.; Orsi, F.; Seppanen, H.; Torchio, M.; Valenti, D.; Zamboni, G.; Zins, M.; Costa, A.; Poortmans, P.
The evolving role of microsatellite instability in colorectal cancer: A review 1-gen-2016 Gelsomino, Fabio; Barbolini, Monica; Spallanzani, Andrea; Pugliese, Giuseppe; Cascinu, Stefano
Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options 1-gen-2011 L., Faloppi; M., Scartozzi; E., Maccaroni; M. D., Pietro; R., Berardi; M. D., Prete; Cascinu, Stefano
Fertility preservation in women with borderline ovarian tumours. 1-gen-2016 Mangili, G; Somigliana, E; Giorgione, V; Martinelli, F; Filippi, F; Petrella, Mc; Candiani, Massimo; Peccatori, F.
Gastric cancer: Translating novels concepts into clinical practice 1-gen-2019 Salati, M.; Orsi, G.; Smyth, E.; Beretta, G.; De Vita, F.; Di Bartolomeo, M.; Fanotto, V.; Lonardi, S.; Morano, F.; Pietrantonio, F.; Pinto, C.; Rimassa, L.; Vasile, E.; Vivaldi, C.; Zaniboni, A.; Ziranu, P.; Cascinu, S.
Hereditary prostate cancer – Primetime for genetic testing? 1-gen-2019 Heidegger, I.; Tsaur, I.; Borgmann, H.; Surcel, C.; Kretschmer, A.; Mathieu, R.; Visschere, P. D.; Valerio, M.; van den Bergh, R. C. N.; Ost, P.; Tilki, D.; Gandaglia, G.; Ploussard, G.
Imaging and clinical correlates with regorafenib in metastatic colorectal cancer 1-gen-2020 Khan, K.; Cascinu, S.; Cunningham, D.; Kim, S. -Y.; Oki, E.; Seery, T.; Shen, L.; Siena, S.; Tournigand, C.; Turhal, N. S.; Hendlisz, A.
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 1-gen-2022 Martini, Alberto; Raggi, Daniele; Fallara, Giuseppe; Nocera, Luigi; Schultz, Julianne G; Belladelli, Federico; Marandino, Laura; Salonia, Andrea; Briganti, Alberto; Montorsi, Francesco; Powles, Thomas; Necchi, Andrea
Metabolic alterations in renal cell carcinoma 1-gen-2015 Massari, F.; Ciccarese, C.; Santoni, M.; Brunelli, M.; Piva, F.; Modena, A.; Bimbatti, D.; Fantinel, E.; Santini, D.; Cheng, L.; Cascinu, S.; Montironi, R.; Tortora, G.
Neoadjuvant therapy in resectable pancreatic cancer: A critical review 1-gen-2013 Belli, C; Cereda, S; Anand, S; Reni, M
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence 1-gen-2019 Seufferlein, T.; Hammel, P.; Delpero, J. R.; Macarulla, T.; Pfeiffer, P.; Prager, G. W.; Reni, M.; Falconi, M.; Philip, P. A.; Van Cutsem, E.
Mostrati risultati da 1 a 20 di 31
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile